v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating activities    
Net earnings $ 12,151 $ 10,046
Noncash items:    
Depreciation and amortization 2,069 2,145
Deferred income taxes 411 (87)
Share-based compensation 624 572
Loss on sale of subsidiary and subsidiaries held for sale 133 56
Other, net (235) 127
Net change in other operating items, net of effects from acquisitions and dispositions:    
Accounts receivable 1,481 (1,681)
Other assets 3,020 (2,143)
Medical costs payable (420) 4,371
Accounts payable and other liabilities 1,152 (480)
Unearned revenues (422) (282)
Cash flows from operating activities 19,964 12,644
Investing activities    
Purchases of investments (10,125) (8,180)
Sales of investments 2,664 5,181
Maturities of investments 4,710 4,326
Cash paid for acquisitions and other transactions, net of cash assumed (98) (734)
Purchases of property, equipment and capitalized software (1,562) (1,784)
Repayments of care provider loans - cyberattack 197 1,293
Originations And Purchases Of Loans (2,745) (2,225)
Repayments and maturities of loans 1,424 588
Cash received from dispositions and other strategic transactions, net 1,091 109
Other, net 199 (90)
Cash flows used for investing activities (4,245) (1,516)
Financing activities    
Common share repurchases (1,646) (5,545)
Cash dividends paid (4,092) (3,912)
Proceeds from common stock issuances 359 581
Repayments of long-term debt (2,500) 0
Repayments of short-term borrowings, net (2,313) (1,403)
Proceeds from Issuance of Long-Term Debt 0 2,969
Customer funds administered 332 (25)
Other, net (1,755) (513)
Cash flows used for financing activities (11,615) (7,848)
Effect of exchange rate changes on cash and cash equivalents (3) 29
Increase in cash and cash equivalents, including cash within businesses held for sale 4,101 3,309
Less: net change in cash within businesses held for sale 119 (25)
Net increase in cash and cash equivalents 4,220 3,284
Cash and cash equivalents, beginning of period 24,365 25,312
Cash and cash equivalents, end of period $ 28,585 $ 28,596